Clinical trial
Comparison of the Effect of Fenofibrate Versus Curcumin in Type 2 Diabetic Patients Treated With Glimepiride
NCT04528212 is registered in ClinicalTrials.gov with Rehab Werida as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of the Effect of Fenofibrate Versus Curcumin in Type 2 Diabetic Patients Treated With Glimepiride
- Lead sponsor
- Rehab Werida
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 1, 2020
- Completion date
- December 1, 2021
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.